Literature DB >> 23714093

Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244,768 controls.

Su-Yu Miao1, Wenbin Zhou, Ling Chen, Shui Wang, Xiao-An Liu.   

Abstract

AIM: Blood group is an important risk factor for some malignancies, including pancreatic and stomach cancer. However, it is unclear whether the risk of breast cancer is higher in any specific ABO blood type.
METHODS: We searched the electronic database of PubMed, EMBASE, China National Knowledge Infrastructure and the VIP Chinese Journal of Science and Technology for case-control studies about blood type and breast cancer incidence, and a meta-analysis was conducted.
RESULTS: Fourteen studies were eligible for assessment on the association of breast cancer with different blood types, including 9665 breast cancer patients and 244,768 controls. Relative to blood type O, women with blood type A (odds ratio (OR) = 1.115, 95% confidence interval (CI) 0.992-1.254), B (OR = 0.983, 95% CI 0.915-1.056) and AB (OR = 1.042, 95% CI 0.881-1.231) had the same breast cancer risk. The risk for women with Rhesus-positive (Rh+) was the same as those with Rh-negative (Rh-) (OR = 0.948, 95% CI 0.667-1.348). Among Caucasians, the OR of blood type A was 1.066 (95% CI, 1.001-1.134, P = 0.522 for heterogeneity).
CONCLUSION: This meta-analysis suggests Caucasians with blood type A may have a higher risk of breast cancer than other Caucasians. No association was found in any other blood type or any other population. Similarly, the Rh factor had no association with the risk of breast cancer.
© 2013 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  ABO; Rh; breast cancer; meta-analysis; risk

Mesh:

Substances:

Year:  2013        PMID: 23714093     DOI: 10.1111/ajco.12083

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  16 in total

Review 1.  Blood type biochemistry and human disease.

Authors:  D Rose Ewald; Susan C J Sumner
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-09-07

Review 2.  Hemostasis, cancer, and ABO blood group: the most recent evidence of association.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  J Thromb Thrombolysis       Date:  2014       Impact factor: 2.300

Review 3.  The prognostic value of ABO blood group in cancer patients.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Giuseppe Lippi
Journal:  Blood Transfus       Date:  2015-11-06       Impact factor: 3.443

4.  Relationship between ABO blood group and gestational diabetes mellitus: A protocol for systematic review and meta-analysis.

Authors:  Dongyun Chen; Lili Lin; Qiong Hong; Xiaohong Li
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

5.  Prognostic Correlations between ABO Blood Group and Pre-Treatment Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy.

Authors:  Hao Peng; Lei Chen; Wen-Fei Li; Yuan Zhang; Li-Zhi Liu; Li Tian; Ai-Hua Lin; Ying Sun; Jun Ma
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

Review 6.  The role of the histoblood ABO group in cancer.

Authors:  Seth K Rummel; Rachel E Ellsworth
Journal:  Future Sci OA       Date:  2016-03-15

7.  ABO blood groups as a prognostic factor for recurrence in ovarian and vulvar cancer.

Authors:  Céline Montavon Sartorius; Andreas Schoetzau; Henriette Kettelhack; Daniel Fink; Neville F Hacker; André Fedier; Francis Jacob; Viola Heinzelmann-Schwarz
Journal:  PLoS One       Date:  2018-03-29       Impact factor: 3.240

8.  Clinical Associations with ABO Blood Group and Rhesus Blood Group Status in Patients with Breast Cancer: A Nationwide Retrospective Study of 3,944 Breast Cancer Patients in Turkey.

Authors:  Serkan Akin; Kadri Altundag
Journal:  Med Sci Monit       Date:  2018-07-07

9.  Serum amylase activity altered by the ABO blood group system in Chinese subjects.

Authors:  You-Fan Peng; Hemant Goyal; Hao Lin; De-Chen Liu; Ling Li
Journal:  J Clin Lab Anal       Date:  2019-04-02       Impact factor: 2.352

10.  The ABO blood group is an independent prognostic factor in patients with resected non-small cell lung cancer.

Authors:  Koichi Fukumoto; Tetsuo Taniguchi; Noriyasu Usami; Koji Kawaguchi; Takayuki Fukui; Futoshi Ishiguro; Shota Nakamura; Kohei Yokoi
Journal:  J Epidemiol       Date:  2014-12-06       Impact factor: 3.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.